Cycloartanes with Anticancer Activity Demonstrate Promising inhibition of the Mrckα and Mrckβ Kinases

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2014, Vol 4, Issue 9

Abstract

Aim: The role of Kinases in cancer onset and progression has made kinases a target for the control of some cancers. Recent discoveries that kinases are most effectively inhibited by small molecules have also resulted in an increased search for small molecule kinase inhibitors. Cycloartanes are small molecules found in many medicinal plants including the Jamaican Ball Moss (Tillandsia recurvata). Recent studies on T. recurvata have demonstrated that it possesses anticancer activity. Cycloartane-3,24,25-triol, an analog of a cycloartane identified in Ball moss was also shown to have inhibitory activity against MRCKα kinase. This study was as such set up to determine the MRCKα/β kinase inhibition activity of other cycloartanes in Ball Moss and their analogs. MRCKα/β kinases has been identified as an important kinase implicated in cancer onset and progression and as such a potential drug target. Methodology: Kinase inhibition activity of 6 cycloartanes was investigated using the ligand-kinase binding assay. The WST-1 reagent assay was also used to determine the antiproliferation activity of the cycloartanes against some prostate and breast cancer cell lines. Results: Cycloart-23-ene-3,25-diol (1), Cycloartane-3,24,25-triol (2), Cycloart-25-ene-3,24-diol (3), 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid (4), 24,25-Dihydroxycycloartan-3-one (5) inhibited the MRCKα kinase with Kd of 0.21 μM, 0.25µM, 0.36 µM, 3.0 µM and 2.1 µM respectively. Hydroxycycloart-23-en-3-one,25, (6) showed no inhibition against the MRCKα kinase. Compounds 1, 3, 4, 5 inhibited the MRCKβ kinase with Kd of 4.7 μM, 1.10 µM, 3.2 µM and 9.8 µM, respectively. Three of the six cycloartanes exhibited antiproliferation activity against two prostate and breast cancer cell lines each. Conclusion: Cycloart-23-ene-3,25-diol (1) showed the most promising activity against the MRCKα/β kinase out of the 6 cycloartanes screened demonstrating an interesting structure activity relationship profile when compared with the other molecules. Cycloart-23-ene-3,25-diol (1) deserves further studies to determine its in vivo activity as well.

Authors and Affiliations

Henry I. C. Lowe, Ngeh J. Toyang, Charah T. Watson, Joseph Bryant

Keywords

Related Articles

Atypical Post Partum Eclampsia and Posterior Reversible Encephalopathy Syndrome

Pregnancy induced Hypertension also called as “Gestosis” plural “Gestoses” has a heterogeneous etiology. A case of atypical eclampsia with seizures in the postpartum, that required intravenous Magnesium sulphate is descr...

Role of Genes in Odontogenesis

With the discovery of the homeobox genes in craniofacial biology researchers across the globe have studied in depth the genetic patterning of the craniofacial region. With respect to craniofacial development –, Barx, Dlx...

Human Exposure to Poultry and Poultry Products and the Risk of Death from Hematopoietic & Lymphatic Cancers

Purpose: The purpose of this study was to obtain preliminary information on occupational exposures responsible for the excess of hematopoietic & lymphatic (H&L) cancers previously observed in cohort mortality studies of...

Aspirin as Primary Prevention of Acute Coronary Heart Disease Events

Background/Objective: Aspirin for primary prophylaxis is controversial. This study evaluated associations between prophylactic aspirin use and incident acute coronary heart disease (CHD) events. Methods and Results: The...

Admission Patterns and Outcome in a Pediatric Intensive Care Unit in Nepal

Aims: To study the admission patterns and outcome of children in a Pediatric Intensive Care Unit (PICU) in Nepal. Methods: Demographic profile, diagnosis, treatment, supportive measures and outcome of children admitted t...

Download PDF file
  • EP ID EP348683
  • DOI 10.9734/BJMMR/2014/6877
  • Views 62
  • Downloads 0

How To Cite

Henry I. C. Lowe, Ngeh J. Toyang, Charah T. Watson, Joseph Bryant (2014). Cycloartanes with Anticancer Activity Demonstrate Promising inhibition of the Mrckα and Mrckβ Kinases. Journal of Advances in Medicine and Medical Research, 4(9), 1802-1811. https://europub.co.uk./articles/-A-348683